This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Other lower respiratory disease
  • /
  • Efficacy and safety of nintedanib in idiopathic pu...

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.

Read time: 1 mins
Published:29th May 2019
Author: Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U et al.
Availability: Free full text
Ref.:N Engl J Med. 2014;370(22):2071-82.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest